
Pieris Pharmaceuticals Investor Relations Material
Latest events

Business Combination
Pieris Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Pieris Pharmaceuticals Inc
Access all reports
Pieris Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on the discovery and development of Anticalin-based therapies, which are engineered proteins designed to treat respiratory diseases, cancer, and other conditions. The company’s proprietary Anticalin platform allows for the creation of novel biologics that target specific disease pathways. Pieris is developing a pipeline of therapies for immuno-oncology, asthma, and other respiratory conditions, working both independently and through collaborations with pharmaceutical partners. The company is headquartered in Boston, Massachusetts, and its shares are listed on the Nasdaq.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
PIRS
Country
🇺🇸 United States